Electromechanical integration of cardiomyocytes derived from human embryonic stem cells
By I. Kehat, L. Khimovich, O. Caspi, A. Gepstein, R. Shofti, G. Arbel, I. Huber, J. Satin, J. Itskovitz‐Eldor, L. Gepstein. Nature Biotechnology, 2004
895 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Molecular Biology, Surgery
View Paper: https://www.semanticscholar.org/paper/c5225a1ecb27c514b05a29f4d588cb2955c7a877
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
In Molecular Biology
- Charles E. Murry
- G. Keller
- M. Laflamme
- Joseph D. Gold
- Nikolaos G. Frangogiannis
- H. Ruskoaho
- Virpi Talman
In Surgery
Citations in the corpus
- Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. (2008, background): “When cardiomyocytes from human ESCs were similarly transplanted into the uninjured hearts of immunocompromised mice, rats, and pigs, they formed grafts of human myocardium (Dai et al., 2007; Kehat et al., 2004; Laflamme et al., 2005).”
- Regenerating the heart (2005, background): “In vivo studies with human ES cell-derived cardiomyocytes are just beginning, and there are only three published studies describing their successful applicatio”
- Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts (2007, background): “Initial studies with hES cell–derived cardiomyocytes have shown their capacity to form new myocardium in the uninjured hear”
- Embryonic stem cell differentiation: emergence of a new era in biology and medicine. (2005, methodology): “Recently, hES-cell-derived cardiomyocytes have been used in xenogeneic transplantation as “biologic pacemakers” for the treatment of bradycardia (Kehat et al. 2004).”